A Randomised, Controlled, Multicenter Study to Comparing the Effect of Icotinib plus Intercalated Chemotherapy Combination therapy with Icotinib Alone Therapy as First-line Treatment for Patients with Non-Small-Cell Lung Cancer

Trial Profile

A Randomised, Controlled, Multicenter Study to Comparing the Effect of Icotinib plus Intercalated Chemotherapy Combination therapy with Icotinib Alone Therapy as First-line Treatment for Patients with Non-Small-Cell Lung Cancer

Recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Icotinib (Primary) ; Antineoplastics
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top